Chartreusin, a glycosidic antitumour antibiotic from Streptomyces.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001578:Benzopyrans; D055598:Chemical Phenomena; D002621:Chemistry; D006027:Glycosides / Q000096:biosynthesis / Q000627:therapeutic use*; D007942:Leukemia, Experimental / Q000188:drug therapy; D020648:Peptide Elongation Factor 1; D010445:Peptide Elongation Factors / Q000378:metabolism; D012346:RNA, Transfer, Amino Acyl / Q000378:metabolism; D012270:Ribosomes / Q000378:metabolism; D013302:Streptomyces / Q000032:analysis*
D000903:Antibiotics, Antineoplastic; D001578:Benzopyrans; D006027:Glycosides; D020648:Peptide Elongation Factor 1; D010445:Peptide Elongation Factors; D012346:RNA, Transfer, Amino Acyl; C002185:chartreusin